Patients and Methods
A total of 139 patients with bipolar I disorder enrolled in the Stanley Foundation Bipolar Network from 1996 through 2002 were included in the study. All participants completed a variety of assessments, including a detailed patient questionnaire and retrospective and prospective graphing of their course of illness and pharmacologic therapy using the National Institute of Mental Health-Life Chart Method (NIMH-LCM). They received naturalistic treatment during their time in the network. The primary outcome was prospective response to naturalistic treatment for ≥6 months, defi ned as a good to excellent response using the Clinical Global Impressions scale (CGI-BP).
The number of antidepressant trials and total duration of antidepressant treatment were recorded. The number and duration of trials with and without "coverage" of a mood stabilizer for ≥75% of the time of antidepressant use were related to the primary outcome.
Factors Associated with Response to Treatment
Of the 139 subjects, 108 were ill at study entry and required additional treatment to achieve response or to be classifi ed as nonresponders. A total of 60 patients were classifi ed as responders and 48 as nonresponders. Among the overall population, 104 (75%) had a positive history of antidepressant exposure, while 86 (80%) of the ill patients at entry had previously used antidepressants.
Univariate analysis demonstrated a highly significant association of nonresponse with the more antidepressant trials and longer duration of antidepressant treatment regardless of mood stabilizer coverage (Table) . Logistic re- gression analysis showed prospective long-term response was associated with the number of antidepressant trials (P = .0051), history of comorbid anxiety disorder, and number of prior mood episodes (Figure) . On regression analysis the duration of antidepressant treatment was not an independent predictor. The odds ratios (OR) for total (OR, 1.42; P = .007), covered (OR, 1.55; P = .041), and uncovered (OR, 1.56; P = .029) antidepressant trials were similar, suggesting that the three variables predicted prospective treatment response equally well. Patients with more than 20 prior mood episodes participated in 2.1 times more total antidepressant trials (P = .005) and 2.4 times more covered antidepressant trials (P = .018).
Repeated Antidepressant Use Related to Poor Response
This study demonstrates an association between participation in a greater number of previous antidepressant trials and a poorer subsequent long-term outcome of naturalistic treatment in patients with bipolar I disorder. These results suggest that repeated use of antidepressants but not duration of treatment for depressive episodes is related to poor prospective response. It is unclear whether more antidepressant trials led to increased treatment resistance or whether more episodes and anxiety comorbidity led to more attempts at antidepressant treatment. 
